Artificial Skin Market

Global Artificial Skin Market Size (2024 to 2032)

The global artificial skin market is predicted to grow at a CAGR of 6.4% during the forecast period.

Artificial Skin is a synthetic substitute for human Skin that can stimulate skin regeneration, dramatically improving the treatment of severe burns and injuries. The epidermis and dermis are the two layers of the Skin, the human body's largest organ. Severe burns and wounds expose the body to infection and slow the healing process. Artificial skin aids in overcoming these barriers and speeds wound and burn to healing. Epicel, alloderm, and Integra are three types of permanent artificial Skin currently on the market. Epicel, also known as a cultivated epithelial autograft, is a type of epithelial autograft. Before being utilized as a graft, it is created from the patient's Skin and cultivated for two to three weeks. In the case of deep wounds, alloderm is used to repair injured soft tissue. It isn't suitable for huge surfaces. Integra is a long-lasting synthetic skin substitute that encourages cell proliferation and aids in creating red blood cells.

MARKET DRIVERS

Y-O-Y growth in the incidence of acute and chronic wounds is one of the significant factors driving the global artificial skin market.

As people become more aware of the various skin treatment choices, artificial Skin is becoming more popular. Because artificial Skin lacks immunogenic cells such as dendritic cells, auto rejection does not occur. The artificial skin market has grown significantly as the incidence of vehicle accidents, burns, and trauma-related incidents have increased. Increased incidence of burn injuries, rise in prevalence of chronic & acute wounds such as diabetic foot ulcers, the surge in R&D efforts for the development of new products, technological advancements such as sprays for treating burn injuries using the patient's cells for rapid recovery, and increase in health care expenditure in developed and developing countries are expected to drive the global artificial skin market.

Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are challenging to cure and costly to treat, putting a significant financial strain on healthcare systems. In addition, chronic wounds are being formed due to the increased adoption of sedentary lifestyles, unhealthy eating habits, and the aggravation of chronic diseases such as obesity and diabetes. As a result of the rising number of diabetic and obese patients, the demand for quick wound healing has expanded dramatically. Over the forecast period, these factors are expected to boost demand for regenerating artificial Skin.

The product's launch in Japan is expected to be a profitable opportunity for AVITA Medical, as the number of patients suffering from chronic wounds and decubitus ulcers in Japan has increased in recent years. Manufacturers seek ways to produce new products by regularly investing in research and development. Due to growing competition, the profit margins of established suppliers are decreasing as new vendors enter the market. To maintain their market positions, incumbent vendors are being pushed to develop new goods by increasing their R&D spending.

MARKET RESTRAINTS

High costs associated with artificial skin are majorly hindering global market growth.

Lack of awareness over the availability of different treatment options for diabetic ulcers or skin wounds primarily hinders the growth rate of the artificial skin market. Also, the costs of artificial skin treatment procedures are very high, and common people cannot afford them, slowly degrading the growth rate of the market. Government authorities fail to provide reimbursement schemes for this kind of treatment procedure, which is attributed to negatively impacting the growth rate of the artificial skin market. Stringent rules and regulations by the government in approving innovative surgical procedures for skin care in favor of public safety slightly impede the potential growth rate of the market. 

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Artificial Skin Market Analysis By Product Type

The permanent artificial skin market is leading with the dominant share of the market. The growing prominence of wound healing procedures with the latest technologies among patients is driving the growth rate of this segment. Many patients who are suffering from skin ulcers are showing interest in medical treatment to restore skin functionality in various ways. This attribute is also likely to elevate the growth rate of the market. The temporary segment is ascribed to have a prominent growth rate during the forecast period. Increasing prominence to avail various options for wound care is driving the demand for temporary artificial skin treatment procedures that are anticipated to fuelling the segment’s growth rate. 

Global Artificial Skin Market Analysis By Material

The dermal segment is leading with the highest share of the market, whereas the epidermal segment is gaining traction over the growth rate of the market. Sedentary lifestyle changes are one of the common factors for the rising number of chronic diseases across the world. Food habits changes and lack of physical activities due to the adoption of a sedentary lifestyle are increasing the chances of diabetes, which is commonly related to the rising risk of skin ulcers. Creating awareness in urban areas of the various treatment procedures for the wound healing process is anticipated to increase the growth rate of the artificial skin market. 

Global Artificial Skin Market Analysis By Application

Chronic wounds segment is ruling with the highest share of the market. Artificial skin treatment for the chronic wounds is highly recommended to prevent infection, and loss of fluids to promote the wound healing at faster rate. Acute wounds segment is set to showcase high growth opportunities during the forecast period. 

Global Artificial Skin Market Analysis By End User

Hospitals segment is holding the largest share of the artificial skin market from past few years whereas burn care C segment is likely to have the prominent growth rate in the foreseen years. Rising investments to expand the healthcare facilities by government authorities is greatly influencing the growth rate of the market. Burn care C segment is to have steady growth rate in the coming years. 

On the other hand, the burn care centers segment is expected to grow at a promising CAGR during the forecast period.

REGIONAL ANALYSIS

North America is expected to dominate the worldwide artificial skin market during the forecast period. This is due to a favorable regulatory environment and increased burn injuries, which have increased the demand for permanent artificial Skin for effective burn therapy. Manufacturers seek ways to produce new products by regularly investing in research and development. By the American Burn Association, nearly 40,000 patients were hospitalized in the United States for burn injuries between 2017 and 2018. Other major national organizations have produced similar studies on burn injuries. According to the Centers for Disease Control and Prevention, over 10,000 people in the United States die each year from diseases induced by burn injuries. More activities to raise awareness of Skin and tissue donation are being implemented to support market growth. Donate Life America, and other organizations are increasing awareness programs to raise awareness of skin illnesses that necessitate replacement operations and skin donation. Donate Life America is a non-profit organization promoting organ, eye, and tissue donation.

Due to increased research and development efforts, increased government initiatives for improving health care, and a surge in critical players' focus on developing or reinforcing their presence in the region, the market in the Asia Pacific is expected to grow quickly rate during the forecast period. As a result, the APAC artificial skin market is growing significantly and is predicted to register a CAGR of 8.33% from 2022 to 2032.

During the forecast period, the artificial skin market in Europe is expected to showcase a CAGR of 5.58%.

KEY PLAYERS IN THE GLOBAL ARTIFICIAL SKIN MARKET

AVITA Medical, Eucare Pharmaceuticals (P) Ltd., MiMedx, Aroa Biosurgery Limited, Integra LifeSciences, Mallinckrodt Pharmaceuticals, Medskin Suwelack, Misonix, and Organogenesis, Inc. are a few of the notable companies operating in the global artificial skin market and profiled in this report.

RECENT HAPPENINGS IN THE MARKET

• AVITA Medical and COSMOTEC, a subsidiary of M3 Group Company, partnered on March 4, 2019, to sell and distribute RECELL in Japan, intended to treat wounds caused by burns and other injuries.
• 3M announced the acquisition of Acelity Inc. in October 2019 and its KCI subsidiaries; a global medical technology firm focused on enhanced wound management.

DETAILED SEGMENTATION OF THE GLOBAL ARTIFICIAL SKIN MARKET INCLUDED IN THIS REPORT

This research report on the global artificial skin market has been segmented and sub-segmented based on product type, replacement area, material, application, end-user & region.

By Product Type

• Permanent
• Temporary
• Composite

By Replacement area

• Dermal
• Epidermal
• Composed

By Material

• Natural
• Synthetic
• Both

By Application

• Acute wounds
• Chronic wounds
• Others

By End User

• Hospitals
• Burn care Centers
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa